Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future

In the first year of its appearance, the 2019 coronavirus disease (COVID-19) has affected more than 150 million individuals and killed 3 million people worldwide. The pandemic has also triggered numerous global initiatives to tackle the newly emerging disease, including the development of SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Hertanto, Decsa Medika, Wiratama, Bayu Satria, Sutanto, Henry, Wungu, Citrawati Dyah Kencono
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312605/
https://www.ncbi.nlm.nih.gov/pubmed/34321903
http://dx.doi.org/10.2147/JIR.S322831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312605/
https://www.ncbi.nlm.nih.gov/pubmed/34321903
http://dx.doi.org/10.2147/JIR.S322831

Ejemplares similares